Intravenous Vitamin C in Combination With Standard Chemotherapy for Pancreatic Cancer
Completed · Phase 1
Conditions studied: Metastatic Pancreatic Cancer
In brief
Eligible candidates will be adults with metastatic pancreatic cancer (confirmed diagnosis with pathology reports and measurable computed tomography (CT) or magnetic resonance imaging (MRI)). Participants must not be receiving any other concurrent chemotherapy, or radiation therapy. Full inclusion/exclusion criteria are available. History and physical examination, and laboratory and imaging analyses will be done within 14 days prior to registration. The three cohorts of subjects will receive 50, 75 or 100 grams of intravenous ascorbic acid, three times per week for 8 weeks. Subjects will also have co-administration of the chemotherapy medications, gemcitabine (intravenously) and erlotinib (orally). Approximately 9 to 18 participants will be enrolled in this Phase I study.
Key facts
- Study ID
- NCT00954525
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- People needed
- 14
- Starts
- 2009-07-01
- Expected to finish
- 2011-12-01
- Last updated by the study team
- 2025-05-02
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Metastatic pancreatic cancer
- Glucose 6 phosphate dehydrogenase status normal
- ECOG performance status 0-2
- Normal creatinine and transaminase
- Women of child-bearing potential confirm negative pregnancy test
You may not qualify if…
- Concurrent chemotherapy or radiotherapy
- Significant co-morbid disorders
- Significant psychiatric symptoms
- Prior treatment with gemcitabine
- Concurrent chronic use of immunosuppressive agents (methotrexate, cyclosporine,corticosteroids)
- Regular use of nonsteroidal anti-inflammatory agents
- Smoking more than 1 pack per day
- Excessive alcohol or drug use
- Enrollment in other experimental therapy
- Active infection
- Patients experiencing ongoing response to recent treatments
Where it is running
- Jefferson-Myrna Brind Center of Integrative Medicine — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.